Bank of America’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.31B | Sell |
46,545,479
-2,235,713
| -5% | -$59.5M | 0.1% | 200 |
|
|
2025
Q4 | $1.21B | Buy |
48,781,192
+4,366,553
| +10% | +$110M | 0.09% | 217 |
|
|
2025
Q3 | $1.13B | Sell |
44,414,639
-7,045,690
| -14% | -$174M | 0.08% | 247 |
|
|
2025
Q2 | $1.25B | Sell |
51,460,329
-4,605,135
| -8% | -$107M | 0.09% | 221 |
|
|
2025
Q1 | $1.42B | Buy |
56,065,464
+10,960,392
| +24% | +$287M | 0.11% | 174 |
|
|
2024
Q4 | $1.2B | Sell |
45,105,072
-9,257,465
| -17% | -$251M | 0.1% | 197 |
|
|
2024
Q3 | $1.57B | Buy |
54,362,537
+1,975,559
| +4% | +$57.6M | 0.13% | 165 |
|
|
2024
Q2 | $1.47B | Sell |
52,386,978
-120,785
| -0.2% | -$3.33M | 0.13% | 166 |
|
|
2024
Q1 | $1.46B | Buy |
52,507,763
+4,621,652
| +10% | +$128M | 0.13% | 162 |
|
|
2023
Q4 | $1.38B | Sell |
47,886,111
-4,308,831
| -8% | -$130M | 0.14% | 155 |
|
|
2023
Q3 | $1.73B | Sell |
52,194,942
-7,424,120
| -12% | -$263M | 0.19% | 120 |
|
|
2023
Q2 | $2.19B | Sell |
59,619,062
-5,182,137
| -8% | -$202M | 0.23% | 94 |
|
|
2023
Q1 | $2.64B | Buy |
64,801,199
+2,341,308
| +4% | +$101M | 0.27% | 81 |
|
|
2022
Q4 | $3.2B | Buy |
62,459,891
+1,199,714
| +2% | +$57.5M | 0.36% | 56 |
|
|
2022
Q3 | $2.68B | Sell |
61,260,177
-517,033
| -0.8% | -$25.1M | 0.32% | 65 |
|
|
2022
Q2 | $3.24B | Buy |
61,777,210
+2,779,143
| +5% | +$142M | 0.37% | 53 |
|
|
2022
Q1 | $3.05B | Buy |
58,998,067
+1,549,832
| +3% | +$80.4M | 0.3% | 72 |
|
|
2021
Q4 | $3.39B | Buy |
57,448,235
+16,760
| +0% | +$830K | 0.33% | 61 |
|
|
2021
Q3 | $2.47B | Sell |
57,431,475
-6,486,515
| -10% | -$287M | 0.25% | 83 |
|
|
2021
Q2 | $2.5B | Sell |
63,917,990
-3,933,416
| -6% | -$153M | 0.26% | 84 |
|
|
2021
Q1 | $2.46B | Sell |
67,851,406
-639,558
| -0.9% | -$22.7M | 0.28% | 79 |
|
|
2020
Q4 | $2.52B | Sell |
68,490,964
-16,712,640
| -20% | -$613M | 0.32% | 71 |
|
|
2020
Q3 | $2.97B | Buy |
85,203,604
+2,564,074
| +3% | +$89.9M | 0.4% | 56 |
|
|
2020
Q2 | $2.56B | Sell |
82,639,530
-8,708,799
| -10% | -$296M | 0.39% | 50 |
|
|
2020
Q1 | $2.83B | Sell |
91,348,329
-12,896,217
| -12% | -$439M | 0.51% | 37 |
|
|
2019
Q4 | $3.88B | Sell |
104,244,546
-5,272,143
| -5% | -$188M | 0.56% | 30 |
|
|
2019
Q3 | $3.73B | Buy |
109,516,689
+2,497,478
| +2% | +$90.8M | 0.55% | 30 |
|
|
2019
Q2 | $4.4B | Buy |
107,019,211
+8,117,279
| +8% | +$322M | 0.67% | 20 |
|
|
2019
Q1 | $3.99B | Sell |
98,901,932
-6,141,356
| -6% | -$246M | 0.62% | 23 |
|
|
2018
Q4 | $4.35B | Sell |
105,043,288
-4,619,503
| -4% | -$192M | 0.76% | 18 |
|
|
2018
Q3 | $4.59B | Sell |
109,662,791
-3,245,529
| -3% | -$125M | 0.71% | 21 |
|
|
2018
Q2 | $3.89B | Buy |
112,908,320
+264,877
| +0.2% | +$9.05M | 0.64% | 22 |
|
|
2018
Q1 | $3.79B | Sell |
112,643,443
-11,603,723
| -9% | -$399M | 0.65% | 21 |
|
|
2017
Q4 | $4.27B | Sell |
124,247,166
-17,303,218
| -12% | -$590M | 0.71% | 19 |
|
|
2017
Q3 | $4.79B | Buy |
141,550,384
+14,028,578
| +11% | +$451M | 0.76% | 12 |
|
|
2017
Q2 | $4.06B | Buy |
127,521,806
+877,568
| +0.7% | +$27.7M | 0.81% | 8 |
|
|
2017
Q1 | $4.11B | Buy |
126,644,238
+2,790,335
| +2% | +$88M | 0.82% | 8 |
|
|
2016
Q4 | $3.82B | Buy |
123,853,903
+4,298,874
| +4% | +$131M | 0.83% | 8 |
|
|
2016
Q3 | $3.84B | Buy |
119,555,029
+8,391,621
| +8% | +$281M | 0.84% | 9 |
|
|
2016
Q2 | $3.71B | Buy |
111,163,408
+1,935,195
| +2% | +$61.8M | 0.86% | 7 |
|
|
2016
Q1 | $3.07B | Buy |
109,228,213
+25,218,753
| +30% | +$720M | 0.75% | 12 |
|
|
2015
Q4 | $2.57B | Buy |
84,009,460
+2,600,126
| +3% | +$81.8M | 0.61% | 20 |
|
|
2015
Q3 | $2.43B | Buy |
81,409,334
+27,271,641
| +50% | +$874M | 0.6% | 20 |
|
|
2015
Q2 | $1.72B | Sell |
54,137,693
-234,694
| -0.4% | -$7.65M | 0.56% | 22 |
|
|
2015
Q1 | $1.79B | Buy |
54,372,387
+8,857,894
| +19% | +$282M | 0.6% | 16 |
|
|
2014
Q4 | $1.35B | Sell |
45,514,493
-10,800,592
| -19% | -$310M | 0.48% | 25 |
|
|
2014
Q3 | $1.58B | Buy |
56,315,085
+2,327,488
| +4% | +$65.3M | 0.51% | 26 |
|
|
2014
Q2 | $1.52B | Buy |
53,987,597
+2,465,789
| +5% | +$70.3M | 0.49% | 33 |
|
|
2014
Q1 | $1.57B | Sell |
51,521,808
-1,514,751
| -3% | -$45.2M | 0.58% | 20 |
|
|
2013
Q4 | $1.54B | Buy |
53,036,559
+1,077,373
| +2% | +$31.4M | 0.55% | 21 |
|
|
2013
Q3 | $1.42B | Sell |
51,959,186
-27,768,502
| -35% | -$756M | 0.56% | 24 |
|
|
2013
Q2 | $2.12B | Buy |
+79,727,688
| New | +$2.2B | 0.89% | 7 |
|
Other funds holding PFE
VCM
VPM
Bank of America's PFE Position: Q1 2026 in Review
Bank of America reduced its Pfizer (PFE) stake by 4.6% in Q1 2026, selling an estimated $59.5M and leaving 46,545,479 shares worth $1.31B. The position accounts for 0.1% of the portfolio, ranked #200.
Bank of America first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.79B in Q3 2017. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bank of America held 46,545,479 shares of Pfizer worth $1.31B as of Q1 2026.
- Bank of America sold 2,235,713 Pfizer shares in Q1 2026, an estimated $59.5M.
- Pfizer made up 0.1% of Bank of America's portfolio in Q1 2026, its #200 holding.
- Bank of America first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Pfizer position peaked at $4.79B in Q3 2017.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.